These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Diverse structural solutions to catalysis in a family of antibodies. Gigant B; Tsumuraya T; Fujii I; Knossow M Structure; 1999 Nov; 7(11):1385-93. PubMed ID: 10574796 [TBL] [Abstract][Full Text] [Related]
3. Structural convergence in the active sites of a family of catalytic antibodies. Charbonnier JB; Golinelli-Pimpaneau B; Gigant B; Tawfik DS; Chap R; Schindler DG; Kim SH; Green BS; Eshhar Z; Knossow M Science; 1997 Feb; 275(5303):1140-2. PubMed ID: 9027317 [TBL] [Abstract][Full Text] [Related]
4. Routes to catalysis: structure of a catalytic antibody and comparison with its natural counterpart. Haynes MR; Stura EA; Hilvert D; Wilson IA Science; 1994 Feb; 263(5147):646-52. PubMed ID: 8303271 [TBL] [Abstract][Full Text] [Related]
5. Critical analysis of antibody catalysis. Hilvert D Annu Rev Biochem; 2000; 69():751-93. PubMed ID: 10966475 [TBL] [Abstract][Full Text] [Related]
6. Transition state docking: a probe for noncovalent catalysis in biological systems. Application to antibody-catalyzed ester hydrolysis. Tantillo DJ; Houk KN J Comput Chem; 2002 Jan; 23(1):84-95. PubMed ID: 11913392 [TBL] [Abstract][Full Text] [Related]
8. Antibody catalysis via strategic use of haptenic charge. Kikuchi K; Hilvert D Acta Chem Scand (Cph); 1996 Apr; 50(4):333-6. PubMed ID: 8639376 [TBL] [Abstract][Full Text] [Related]
9. Structural evidence for a programmed general base in the active site of a catalytic antibody. Golinelli-Pimpaneau B; Goncalves O; Dintinger T; Blanchard D; Knossow M; Tellier C Proc Natl Acad Sci U S A; 2000 Aug; 97(18):9892-5. PubMed ID: 10963661 [TBL] [Abstract][Full Text] [Related]
10. A structural basis for transition-state stabilization in antibody-catalyzed hydrolysis: crystal structures of an abzyme at 1. 8 A resolution. Kristensen O; Vassylyev DG; Tanaka F; Morikawa K; Fujii I J Mol Biol; 1998 Aug; 281(3):501-11. PubMed ID: 9698565 [TBL] [Abstract][Full Text] [Related]
12. Structural basis for antibody catalysis of a disfavored ring closure reaction. Gruber K; Zhou B; Houk KN; Lerner RA; Shevlin CG; Wilson IA Biochemistry; 1999 Jun; 38(22):7062-74. PubMed ID: 10353817 [TBL] [Abstract][Full Text] [Related]
13. Design of the hapten for the induction of antibodies catalyzing aldol reaction. Teraishi K; Saito M; Fujii I; Nakamura H J Mol Graph; 1994 Dec; 12(4):282-5, 292. PubMed ID: 7696219 [TBL] [Abstract][Full Text] [Related]
14. Evolution of shape complementarity and catalytic efficiency from a primordial antibody template. Xu J; Deng Q; Chen J; Houk KN; Bartek J; Hilvert D; Wilson IA Science; 1999 Dec; 286(5448):2345-8. PubMed ID: 10600746 [TBL] [Abstract][Full Text] [Related]
15. Similarities of hydrolytic antibodies revealed by their X-ray structures: a review. Charbonnier JB; Gigant B; Golinelli-Pimpaneau B; Knossow M Biochimie; 1997 Nov; 79(11):653-60. PubMed ID: 9479447 [TBL] [Abstract][Full Text] [Related]
16. Crystal structure of a catalytic antibody with a serine protease active site. Zhou GW; Guo J; Huang W; Fletterick RJ; Scanlan TS Science; 1994 Aug; 265(5175):1059-64. PubMed ID: 8066444 [TBL] [Abstract][Full Text] [Related]
17. Crystal structure of the complex of a catalytic antibody Fab fragment with a transition state analog: structural similarities in esterase-like catalytic antibodies. Charbonnier JB; Carpenter E; Gigant B; Golinelli-Pimpaneau B; Eshhar Z; Green BS; Knossow M Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11721-5. PubMed ID: 8524836 [TBL] [Abstract][Full Text] [Related]
18. Catalytic antibody activity elicited by active immunisation. Evidence for natural variation involving preferential stabilization of the transition state. Gallacher G; Jackson CS; Searcey M; Goel R; Mellor GW; Smith CZ; Brocklehurst K Eur J Biochem; 1993 May; 214(1):197-207. PubMed ID: 8508792 [TBL] [Abstract][Full Text] [Related]